Physician Views Results: Lp(a)-lowering therapies could be the next big thing in cardiovascular disease

[ad_1]

Feedback from our poll of 132 US and European cardiologists suggests considerable enthusiasm for an approach being pursued by multiple big pharma companies.

Sources

1/ https://Google.com/

2/ https://firstwordpharma.com/story/5949116

The mention sources can contact us to remove/changing this article

[ad_2]

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Posts